Quanterix Corp. priced an underwritten public offering to raise about $60 million in gross proceeds.
The Billerica, Mass.-based precision health company will sell 2,376,238 common stock at $25.25 apiece, and the offering is expected to close on or around Aug. 13. Underwriters have an option to buy up to an additional 356,435 shares from the company.
J.P. Morgan Securities LLC and SVB Leerink LLC are acting as joint book-running managers for the offering. Canaccord Genuity LLC is acting as co-manager for the offering. Perella Weinberg Partners is acting as an independent capital markets adviser to Quanterix for the offering.